Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using gh and GnRHa;Altura quase normal em pacientes com hiperplasia adrenal congênita tratados com a combinação de gh e GnRHa

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 8, 2011, Pages 661-664

  Longui, Carlos Alberto ^a   Kochi, Cristiane ^a   Calliari, Luís Eduardo Procópio ^a   Modkovski, Maria Barcellos Rosa ^a   Soares, Marisa ^a   Alves, Érica Ferreira ^a   Prudente, Fernanda Vilas Boas ^a   Monte, Osmar ^a  

^a IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

Author keywords

Congenital adrenal hyperplasia; GH; GnRHa; Growth recovery; Height

Indexed keywords

GLUCOCORTICOID; GONADORELIN; HUMAN GROWTH HORMONE;

AGE DETERMINATION; ANALYSIS OF VARIANCE; ARTICLE; BODY HEIGHT; CHILD; CONGENITAL ADRENAL HYPERPLASIA; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENAL HYPERPLASIA, CONGENITAL; AGE DETERMINATION BY SKELETON; ANALYSIS OF VARIANCE; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GONADOTROPIN-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; PUBERTY, PRECOCIOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84855437925     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000800023     Document Type: Article

References (9)

1. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase defciency: a meta-analysis. J Pediatr. 2001;138(1):26-32.
2. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropu-los J F, Elamin KB, et al. Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2010;95(9):4161-72.
3. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase defciency. Endocr Rev. 2000;21(3):245-291. Review. Erratum in: Endocr Rev. 2000;21(5):550.
4. Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH--agonist analogue. Ann N Y Acad Sci. 1993;687:250-4.
5. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog. J Clin Endocrinol Metab. 1984;58(5):857-61.
6. Massart F, Federico G, Harrell JC, Saggese G. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty. Neuroendocrinology. 2009;90(3):307-14.
7. Quintos JB, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height defcit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86(4):1511-7.
8. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, et al. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005;90(6):3318-25.
9. Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab. 2011;96(6):1710-7.